Calafat M, Manosa M, Ricart E, Nos P, et al. Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry. J Crohns Colitis 2021 Dec 3. pii: 6448705. doi: 10.1093.
PMID: 34864947